journal clubs | Endocrine and Metabolism Research Center

ردیف	تاریخ ارائه	توضیحات
1	1404/2/18	The Porphyrias Disorders of Heme Synthesis
2	1404/2/11	Guideline for the Prevention and Treatment
3	1404/1/28	HYPERTHYROHDISM
4	1404/1/21	درمان با رادیواکتیو رادیواکتیو لودین
5	1403/12/9	Onset and progression of osteoporosis
6	1403/12/23	Diabetes insipidus
7	1403/12/2	screening or not screening T1D ISPAD 2024 Recommendations
8	1403/12/16	Ramadan and Diabetes
9	1403/11/25	Insulin Resistance and Diabetes Mellitus
10	1403/11/18	Adrenal cortical carcinoma
11	1403/11/11	Management of diabetic foot ulcers
12	1403/10/27	DIABETES AND CANCER
13	1403/10/20	Management of challenging and complicated patients with DM
14	1403/10/13	Dyslipidemia management in pregnant patients: a 2024 update
15	1403/10/06	Adrenal insufficiency:identification and management
16	1403/09/29	Pheochromocytoma and paraganglioma in children
17	1403/09/01	How to manage Cushing’s disease after failed primary pituitary surgery
18	1403/08/24	Surgery of the Adrenal Glands
19	1403/08/24	Surgical Approaches to the Adrenal Gland
20	1403/08/17	Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
21	1403/08/10	Acromegaly
22	1403/08/03	بمپدوییک اسید
23	1403/07/26	postmenopausal osteoporosis
24	1403/07/19	Late night salivary cortisol
25	1403/07/19	Salivary Cortisol test
26	1403/07/12	CKD-MBD
27	1403/07/05	Clinical Indication of FDG PET-CT in DTC
28	1403/04/14	The Genetic Testing in Endocrine Disorders
29	1403/03/31	Cyclic Cushing’s Disease
30	1403/03/20	Primary Aldosteronism Novel Approaches and Future Outlooks
31	1403/03/17	Diabetic Nephropathy
32	1403/03/10	GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
33	1403/03/03	2023 European Thyroid Association Clinical Practice Guidelines for Thyroid nodule management
34	1403/02/27	Bariatric Surgery
35	1403/02/13	Abnormal uterine bleeding in adolescents: Management
36	1403/02/06	Multimodality imaging of primary hyperparthyroidism
37	1403/01/30	Perioperative Evaluation and Management of Patients on Glucocorticoids
38	1403/01/16	Review of ICE 2024
39	1402/12/24	Management of Advanced Thyroid Cancer: Overview, Advances, and Opportunities
40	1402/12/17	Medical Nutrition Therapy IN Diabetes
41	1402/12/10	Diabetic Bladder or Diabetic Cystopathy &related complicationc
42	1402/12/03	The Revolution in Cholesterol Management: Putting REPATHA into practice
43	1402/11/26	EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
44	1402/11/12	Glucocorticoidinduced osteoporosis (GIOP)
45	1402/10/28	Thyroid Scintigraphy
46	1402/10/21	MTC
47	1402/10/14	Summary of Revisions: Standards of Medical Care in Diabetes—2024
48	1402/10/07	Summary of Revisions: Standards of Medical Care in Diabetes—2024
49	1402/09/30	OBESITY MANAGEMENT IN ADULTS
50	1402/09/23	پرولاکتینوما
51	1402/09/16	Updates on Thyroid eye disease
52	1402/09/09	Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines
53	1402/08/25	Nuclear Medicine In Diabetic Foot
54	1402/08/18	Syndrome of Inappropriate Antidiuresis
55	1402/08/11	Hypothyroidism
56	1402/08/04	Management of Osteoporosis in Postmenopausal Woman
57	1402/07/27	نحوه برخورد با شیرخوار مبتلا به ابهام جنسی
58	1402/07/21	PCOS GUIDLINE 2023
59	1402/07/13	Adrenal Incidentaloma
60	1402/07/06	Acromegaly original
61	1401/08/10	Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
62	1400/04/04	A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
63	1400/03/28	Type 1 Diabetes: Management in Women From Preconception to Postpartum
64	1400/03/21	American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool
65	1400/03/07	Vitamin D Update
66	1400/02/31	Active Surveillance of Adult Low-Risk Papillary Thyroid Carcinoma
67	1400/02/17	Management of Hypertriglyceridemia
68	1400/02/10	Adrenal Incidentaloma
69	1400/02/03	Diagnosis and Treatment of NCCAH due to 21-Hydroxylase Deficiency
70	1400/01/27	New Oral Options for Diabetic Dyslipidemia Managment
71	1400/01/20	Testosterone Deficiency in Men
72	1399/12/22	The Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
73	1399/12/15	Role of Nuclear Medicine in Endocrinology
74	1399/12/08	Pituitary Disorders in Pregnancy
75	1399/12/01	IDF DaR Guideline for people with diabetes who want to fast in Ramadan
76	1399/11/24	Thyroid Eye Disease: Managing a Condition with Grave Consequences
77	1399/11/17	Dyslipidemia in Children
78	1399/11/10	Clinical Indication of FDG PET-CT in DTC
79	1399/11/03	Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes
80	1399/10/26	Practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (NET)
81	1399/10/19	Lipid Management in Patients with Endocrine Disorders
82	1399/10/12	Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
83	1399/10/05	ADA 2021 Review
84	1399/09/28	Management of Graves‘ Thyroidal and Extrathyroidal Disease – An Update
85	1399/09/21	Approach to Managing a Postmenopausal Patient
86	1399/09/14	Endocrine Surgery during the Covid-19 pandemic
87	1399/09/07	Turner Syndrome Genome
88	1399/08/30	Glucocorticoid-Induced Osteoporosis
89	1399/08/09	Pituitary Incidentalomas
90	1399/08/02	How to use TBS in combination with BMD in clinical practice
91	1399/07/25	Glucocorticoid Induce Hyperglycemia
92	1399/07/18	Hypoparathyroidism
93	1399/07/11	Normocalcaemic Primary Hyerparathyroidism Normocalcaemic PHP
94	1399/07/04	GLP-1 AGONISTS vs SGLT2-inh ECE 2020
95	1399/03/27	PDE5 Inhibitors in Type 2 Diabetes Mellitus
96	1399/03/20	Dietary Fats and Health Outcome
97	1399/03/13	Medical Treatment with Somatostatin Analogues & Predictive Markers for Post-Surgical Medical Management of Acromegaly
98	1399/03/06	Pituitary-Tumor Endocrinopathies
99	1399/02/30	Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
100	1399/02/23	Osteoporosis in Men
101	1399/02/16	PCOS in Adolescents
102	1399/02/09	Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline
103	1399/02/02	Diabetes & Ramadan Fasting - 2020
104	1399/01/26	COVID-19 and Endocrine System
105	1399/01/20	European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
106	1398/11/29	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
107	1398/11/15	Prolactinoma in Pregnancy and Menopause
108	1398/11/08	Nuclear Medicine & Parathyroid Diseases
109	1398/11/01	Management of Hypopituitarism
110	1398/10/24	Thermal Ablation for Papillary Thyroid Microcarcinomas
111	1398/10/17	ADA 2020 - Standards of Medical Care in diabetes
112	1398/10/10	2019European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
113	1398/10/03	Hypogonadism in Men
114	1398/09/26	Prolactinoma in Pregnancy
115	1398/09/19	Familial hypercholesterolemia in children “Diagnosis and Treatment “
116	1398/09/12	Contemporary Debates in Adult Papillary Thyroid Cancer Management
117	1398/09/05	Management Of Graves Orbitopathy
118	1398/08/28	Management of Difficult Osteoporosis
119	1398/08/21	Medical Management of Cushing’s Syndrome
120	1398/08/14	Prolactinoma
121	1398/07/30	Adrenal Crisis
122	1398/07/23	Drug Effects on the Thyroid
123	1398/07/16	Lipid
124	1398/07/09	Pheochromocytoma and Paraganglioma
125	1398/07/02	AROMATASE INHIBITORS AND BONE - ECE 2019
126	1398/03/28	Endocrine Treatment of Gender - Dysphoric/Transsexual Person
127	1398/03/21	Principles of DXA Scan Interpretation
128	1398/03/07	The Indeterminate Thyroid Nodule
129	1398/02/31	Prevention of Type 1 Diabetes
130	1398/02/24	Management of Medullary Thyroid Cancer
131	1398/02/17	Adrenal Imaging
132	1398/02/10	Osteoprosis Recumendations
133	1398/02/03	The Evaluation of Incidentally Discovered Adrenal Masses
134	1398/01/27	Update on Central Precocious Puberty: From Etiologies to Outcomes
135	1398/01/20	Treatment of Diabetes in Older Adults
136	1397/12/21	Diabetes Technology: Standards of Medical Care in Diabetes 2019
137	1397/12/14	The Management of Primary Aldosteronism Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
138	1397/12/07	Sglt2 Inhibitor
139	1397/11/30	Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
140	1397/11/23	BMD
141	1397/11/16	Thyroid and Pregnancy
142	1397/11/09	Long-term Safety & Efficacy of GH Treatment
143	1397/11/02	Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
144	1397/10/25	The Diagnosis and Management of Nonalcoholic Fatty Liver Disease
145	1397/10/18	Gaps in Guidelines for the Management of Diabetes in Low and Middle-Income Versus High-Income Countries: A Systematic Review
146	1397/10/11	RAI in low risk DTC
147	1397/10/04	Management of Hyperglycemia in Type 2 Diabetes, 2018
148	1397/09/27	Diabetic Neuropathy
149	1397/09/20	OSTEOGENESIS IMPERFECTA
150	1397/09/13	Conventional & New Treatments of Hypoparathyroidism
151	1397/09/06	CONGENITAL ADRENAL HYPERPLASIA
152	1397/08/29	ORAL SEMAGLUTIDE vs PLACEBO
153	1397/08/15	ACROMEGALY
154	1397/08/01	2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
155	1397/07/24	Adrenocortical Carcinoma
156	1397/07/17	Gestational Diabetes Underpinning Principles, Surveillance, and Management
157	1397/07/10	2018European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
158	1397/07/03	Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
159	1397/03/29	Charcot Foot
160	1397/03/22	X-linked Hypophosphatemic Rickets and its Treatment with Anti-FGF23
161	1397/03/08	Differentiated Thyroid Cancer Subtypes and Prognosis
162	1397/03/01	Incidence of Bone Metastases in Differentiated Thyroid Cancer
163	1397/02/25	Ramadan Fasting & Health
164	1397/02/18	Testosterone Therapy in Men With Hypogonadism
165	1397/02/11	Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
166	1397/01/28	Acromegaly: An Endocrine Society Clinical Practice Guideline
167	1397/01/21	European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
168	1397/01/14	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
169	1396/12/22	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Managment Algorithm-2018 Executive Summary
170	1396/12/15	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
171	1396/12/08	Some Points & Recommendations for Diagnosis Growth Hormone Deficiency in Children and Adolescents
172	1396/11/24	Definition of Pheochromocytomaand Paraganglioma (PPGL)
173	1396/11/17	Magnetic Resonance Imaging of Pituitary Tumors
174	1396/11/10	Diagnosis and Treatment PCOS
175	1396/11/03	Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline
176	1396/10/26	KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, revention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
177	1396/10/19	Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents
178	1396/10/12	Clinically Nonfunctioning Pituitary Adenomas
179	1396/10/05	Standards of Medical Care in Diabetes - 2018
180	1396/09/28	AACE FOR MANAGEMENT OF DYSLIPIDEMIA
181	1396/09/14	Pituitary Apoplexy
182	1396/09/07	Non-Classic Congenital Adrenal Hyperplasia
183	1396/08/30	Nuclear Medicine in Neuroendocrine Tumors
184	1396/08/23	Type 2 Diabetes and Osteoporosis
185	1396/08/16	The Management of Primary Aldosteronism
186	1396/08/09	Prolactinoma
187	1396/08/02	PERIPHERAL PRECOCITY
188	1396/07/25	The follicular-variant papillary thyroid cancer (FVPTC)
189	1396/07/18	Gestational Diabetes Mellitus
190	1396/07/11	Approach to the Patient with Progressive Radioiodine-Refractory Thyroid Cancer - When to Use Systemic Therapy
191	1396/07/04	Management of Graves Orbitopathy ECE2017
192	1396/03/30	Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
193	1396/03/23	Pathogenesis and management of hypoglycemia
194	1396/03/16	Diabetes and Ramadan
195	1396/03/09	Combination Therapy in DM2
196	1396/03/02	Gastrointestinal Manifestations of Diabetes
197	1396/02/26	Ovarian Hyperthecosis
198	1396/02/19	Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
199	1396/02/12	An update on sodium-glucose co transporter-2 inhibitors for the treatment of diabetes mellitus
200	1396/01/15	Physiological and molecular responses to bariatric
201	1395/12/17	Physical activity and exercise in children with diabetes mellitus type 1
202	1395/12/10	Pseudohypoparathyroidism, Albright’s Hereditary Osteodystrophy-Disorders Caused by Inactivating GNAS Mutations
203	1395/11/26	Management of Osteoporosis
204	1395/11/19	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
205	1395/11/12	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
206	1395/11/07	Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly
207		Alcohol Ablation It’s indication, Efficacy, and Safety in Thyroid Disease
208		Central precocious puberty
209		Postoperative Management Following Pituitary Surgery
210		Diabetes and Ramadan: Practical Guidelines
211		The Increasing Incidence of Thyroid Cancer
212		EASD (2016)
213		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules
214		Achieving and Maintaining Weight Loss in Obesity: Clinical Evidence for Novel Approaches
215		European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for phaeochromocytomaor a paraganglioma
216		Approach to diabetes mellitus in children and Adolescents
217		Postmenopausal Osteoporosis
218		Diagnostic tests of cushing syndrome
219		RED CELL TRANSFUSION
220		DPP-4 inhibitors
221		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
222		Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
223		Limitation of current approaches for the treatment of acromegaly
224		COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM
225		Primary ovarian insufficiency (POI)
226		Comprehensive Type 2 Diabetes Managment Algorithm (part 2)
227		Primary Male Hypogonadism and Testosterone Therapy
228		Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
229		Timing of multiple endocrine neoplasia thyroidectomy and extent of central nacklymphadenectomy
230		Hyperglycemia Management In Patients With Post Transplantation Diabetes
231		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
232		Premature Ovarian Failure Clinical Presentation and Treatment
233		Clinical Practice Guidlines for the Diagnosis and Treatment of Postmenopausal Osteoprosis (2016)
234		Premature adrenarche
235		Diabetic Sensory and Motor Neuropathy
236		Update on subclinical thyroid dysfunction
237		Thyroid lymphoma
238		Glinids & Metformin
239		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis
240		Pharmacotherapy for obesity and type 2 diabetes
241		Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR<45 <span data-scayt_word="mL" data-scaytid="146">mL/min) - Dr.Karimifard
242		Postsurgical hypoparathyroidism definitions and management
243		Standards of Medical Care in Diabetes — 2016
244		Thiazolidinediones Alpha and Glucosidase Inhibitors
245		Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly: A Metaanalysis
246		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis part 2